Author:
Wu Di,Shi Yu,Wang ChenChen,Li Cheng,Lu Yaoqin,Wang Chunfang,Zhu Weidong,Sun Tingting,Han Junjie,Zheng Yanling,Zhang Liping
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference81 articles.
1. Saxon DR, Reiter-Brennan C, Blaha MJ, Eckel RH. Cardiometabolic Medicine: development of a New Subspecialty. J Clin Endocrinol Metab 2020, 105(7).
2. Zhang D, Tang X, Shen P, Si Y, Liu X, Xu Z, Wu J, Zhang J, Lu P, Lin H, et al. Multimorbidity of cardiometabolic diseases: prevalence and risk for mortality from one million Chinese adults in a longitudinal cohort study. BMJ Open. 2019;9(3):e024476.
3. Ralston J, Nugent R. Toward a broader response to cardiometabolic disease. Nat Med. 2019;25(11):1644–6.
4. Khan MA, Hashim MJ, Mustafa H, Baniyas MY, Al Suwaidi S, AlKatheeri R, Alblooshi FMK, Almatrooshi M, Alzaabi MEH, Al Darmaki RS, et al. Global epidemiology of Ischemic Heart Disease: results from the global burden of Disease Study. Cureus. 2020;12(7):e9349.
5. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, et al. Global Burden of Cardiovascular diseases and Risk factors, 1990–2019: Update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021.